Previous close | 39.19 |
Open | 39.88 |
Bid | 40.16 x 300 |
Ask | 40.22 x 300 |
Day's range | 39.10 - 40.21 |
52-week range | 15.44 - 40.21 |
Volume | |
Avg. volume | 1,498,029 |
Market cap | 6.854B |
Beta (5Y monthly) | 1.54 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
On May 3, 2024, Jack Anders, the Chief Financial Officer of Revolution Medicines Inc (NASDAQ:RVMD), sold 10,000 shares of the company.
Revolution Medicines, Inc. (NASDAQ:RVMD) Q4 2023 Earnings Call Transcript February 26, 2024 Revolution Medicines, Inc. misses on earnings expectations. Reported EPS is $-1.14 EPS, expectations were $-0.86. Revolution Medicines, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day […]
Revolution Medicines ( NASDAQ:RVMD ) Full Year 2023 Results Key Financial Results Revenue: US$11.6m (down 67% from FY...